Research Summary
AI-generated summary of this SEC filing
Agenus CEO Armen Garo Receives Award of 1.97M Options
What Happened
Armen Garo, Chairman, Chief Executive Officer and Principal Financial Officer of Agenus Inc. (AGEN), was granted a derivative award of 1,971,500 option-equivalent shares on 2026-08-10 (reported on Form 4 filed 2026-08-12). The grant is reported at $0.00 (no immediate cash exchanged). The award is performance-based and divided into five equal tranches that only vest if specific stock-price targets are met (see footnote).
Key Details
- Transaction date: 2026-08-10; Filing date: 2026-08-12.
- Reported transaction type/code: A (Award/Grant). Price reported: $0.00.
- Number of shares/options granted: 1,971,500 (derivative).
- Shares/position after transaction: Not disclosed in this Form 4.
- Footnote (F1): Options split into five equal tranches; each tranche vests only if the company’s stock price sustains, for 30 consecutive calendar days within a five-year performance period, levels equal to 3x, 4x, 5x, 6x and 8x of a $7.78 measurement price, and each tranche also requires a minimum three-year service period.
- Timeliness: Filed within two days of the transaction (not marked late).
Context These are performance-vesting options (derivative awards) rather than an immediate stock purchase or sale. They will only vest—and potentially become exercisable—if both the time (minimum service) and stock-price performance conditions are satisfied during the performance period. Because the grant carries no immediate cash value reported and vests only on hitting high stock-price hurdles, it does not reflect an immediate change in cash position or share ownership and may be dilutive only if and when vesting/exercise occurs.